Xiong Y, Zhang Y, Li X, Qin F, Yuan J. The prevalence and associated factors of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in aging males. Aging Male. 2020;23(5):1432–9.
Morris V, Wagg A. Lower urinary tract symptoms, incontinence and falls in elderly people: time for an intervention study. Int J Clin Pract. 2007;61(2):320–3.
Article CAS PubMed Google Scholar
Parsons JK, Sarma AV, McVary K, Wei JT. Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions. J Urol. 2013;189(1 Suppl):S102–6.
Nørgaard M, Horváth-Puhó E, Corraini P, Sørensen HT, Henderson VW. Sleep disruption and Alzheimer’s disease risk: Inferences from men with benign prostatic hyperplasia. EClinicalMedicine. 2021;32: 100740.
Article PubMed PubMed Central Google Scholar
Lusty A, Siemens DR, Tohidi M, Whitehead M, Tranmer J, Nickel JC. Cardiac Failure Associated with Medical Therapy of Benign Prostatic Hyperplasia: A Population Based Study. J Urol. 2021;205(5):1430–7.
Porto JG, Bhatia AM, Bhat A, Suarez Arbelaez MC, Blachman-Braun R, Shah K, et al. Evaluating transurethral resection of the prostate over twenty years: a systematic review and meta-analysis of randomized clinical trials. World J Urol. 2024;42(1):639.
Article PubMed PubMed Central Google Scholar
Sarier M, Duman I, Kilic S, Yuksel Y, Demir M, Aslan M, et al. Comparative Results of Transurethral Incision with Transurethral Resection of The Prostate in Renal Transplant Recipients with Benign Prostate Hyperplasia. Urol J. 2018;15(4):209–13.
Benzouak T, Addar A, Prudencio-Brunello MA, Saed Aldien A, Amougou SE, AlShammari A, et al. Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis. J Urol. 2025;213(2):150–61. https://doi.org/10.1097/JU.0000000000004297.
Pardo-Rodriguez D, Santamaría-Torres M, Salinas A, Jiménez-Charris E, Mosquera M, Cala MP, et al. Unveiling Disrupted Lipid Metabolism in Benign Prostate Hyperplasia, Prostate Cancer, and Metastatic Patients: Insights from a Colombian Nested Case-Control Study. Cancers (Basel). 2023;15(22):5465. https://doi.org/10.3390/cancers15225465.
Article CAS PubMed PubMed Central Google Scholar
Gacci M, Corona G, Vignozzi L, Salvi M, Serni S, De Nunzio C, et al. Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis. BJU Int. 2015;115(1):24–31.
Bagyura Z, Kiss L, Lux Á, Csobay-Novák C, Jermendy ÁL, Polgár L, et al. Association between coronary atherosclerosis and visceral adiposity index. Nutr Metab Cardiovasc Dis. 2020;30(5):796–803.
Xia BW, Zhao SC, Chen ZP, Chen C, Liu TS, Yang F, et al. The underlying mechanism of metabolic syndrome on benign prostatic hyperplasia and prostate volume. Prostate. 2020;80(6):481–90.
Article CAS PubMed Google Scholar
Rył A, Rotter I, Miazgowski T, Słojewski M, Dołęgowska B, Lubkowska A, et al. Metabolic syndrome and benign prostatic hyperplasia: association or coincidence? Diabetol Metab Syndr. 2015;7:94.
Article PubMed PubMed Central Google Scholar
Li J, Peng L, Cao D, Gou H, Li Y, Wei Q. The association between metabolic syndrome and benign prostatic hyperplasia: a systematic review and meta-analysis. Aging Male. 2020;23(5):1388–99.
Aaron-Brooks LM, Sasaki T, Vickman RE, Wei L, Franco OE, Ji Y, et al. Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse. Prostate. 2019;79(9):980–93.
Article CAS PubMed PubMed Central Google Scholar
Domosławska-Wyderska A, Zduńczyk S, Rafalska A. Potential role of oxidative stress in pathogenesis of benign prostatic hyperplasia in male dogs. Reprod Domest Anim. 2024;59(5): e14580.
Zhang X, Wang Y, Li Y, Gui J, Mei Y, Yang X, et al. Optimal obesity- and lipid-related indices for predicting type 2 diabetes in middle-aged and elderly Chinese. Sci Rep. 2024;14(1):10901.
Article CAS PubMed PubMed Central Google Scholar
Xia MF, Chen Y, Lin HD, Ma H, Li XM, Aleteng Q, et al. A indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese. Sci Rep. 2016;6:38214.
Article CAS PubMed PubMed Central Google Scholar
Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–8.
Xie Z, Liu X, Hu Z, Dong C. Longitudinal association between the dynamic nature of depression with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). BMC Public Health. 2024;24(1):1121.
Article PubMed PubMed Central Google Scholar
Ashwell M, Hsieh SD. Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr. 2005;56(5):303–7.
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
Xia C, Li R, Zhang S, Gong L, Ren W, Wang Z, et al. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr. 2012;66(9):1035–8.
Article CAS PubMed Google Scholar
Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, Midiri M, et al. Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.
Article PubMed PubMed Central Google Scholar
Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazard independently of body mass index. PLoS ONE. 2012;7(7): e39504.
Article CAS PubMed PubMed Central Google Scholar
Xiong Y, Zhang YC, Jin T, Qin F, Yuan JH. Depressive males have higher odds of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a retrospective cohort study based on propensity score matching. Asian J Androl. 2021;23(6):633–9.
Article PubMed PubMed Central Google Scholar
Yang L, Chen X, Liu Z, Sun W, Yu D, Tang H, et al. The Impact of Illness Perceptions on Depressive Symptoms Among Benign Prostatic Hyperplasia Patients with Lower Urinary Tract Symptom. Int J Gen Med. 2021;14:9297–306.
Article PubMed PubMed Central Google Scholar
Ventura S, Oliver V, White CW, Xie JH, Haynes JM, Exintaris B. Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH). Br J Pharmacol. 2011;163(5):891–907.
Article CAS PubMed PubMed Central Google Scholar
Chen W, Man S, Wang B, Kadeerhan G, Huang X. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males. Low Urin Tract Symptoms. 2022;14(3):170–7.
Meng J, Liu Y, Guan SY, Ma H, Zhang X, Fan S, et al. Age, height, BMI and FBG predict prostate volume in ageing benign prostatic hyperplasia: Evidence from 5285 patients. Int J Clin Pract. 2019:e13438. https://doi.org/10.1111/ijcp.13438.
Alshamiri MQ, Mohd AHF, Al-Qahtani SS, Alghalayini KA, Al-Qattan OM, El-Shaer F. Waist-to-Height Ratio (WHtR) in Predicting Coronary Artery Disease Compared to Body Mass Index and Waist Circumference in a Single Center from Saudi Arabia. Cardiol Res Pract. 2020;2020:4250793.
Article PubMed PubMed Central Google Scholar
Britton KA, Massaro JM, Murabito JM, Kreger BE, Hoffmann U, Fox CS. Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality. J Am Coll Cardiol. 2013;62(10):921–5.
Comments (0)